Financhill
Back

Sarepta Therapeutics Stock Predictions

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Sell
31

SRPT
Sarepta Therapeutics

Last Price:
124.92
Seasonality Move:
11.13%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

Sarepta Therapeutics Stock Forecast

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 24.8% based on the past 27 years of stock performance.
  • Sarepta Therapeutics has risen higher in 15 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%
  • Is Sarepta Therapeutics Stock Undervalued?
    The current Sarepta Therapeutics [SRPT] share price is $125.01. The Score for SRPT is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Sarepta Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Sarepta Therapeutics has on average historically risen by 24.8% based on the past 27 years of stock performance.

Sarepta Therapeutics Stock Rating

Sell
31
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics overpriced?

  • Sarepta Therapeutics has risen higher in 15 of those 27 years over the subsequent 52-week period, corresponding to a historical accuracy of 55.56%

Sarepta Therapeutics Stock Price History

Is SRPT stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
sarepta.com

52-Week Data

52-Week High:
173.25
52-Week Low:
75.85

Prediction Charts

Market Cap:
11.92B
Price in USD:
125.01
Volume:
825.63K
Beta:
1.06

Technical Analysis

SMA50:
127.18
SMA100:
135.31
SMA200:
130.57
52-Wk Change:
60.25%

Stock Predictions

  • Is Sarepta Therapeutics stock public?
    Yes, Sarepta Therapeutics is a publicly traded company.
  • What is the Sarepta Therapeutics stock quote today?
    The Sarepta Therapeutics stock price is 125.01 USD today.
  • How to buy Sarepta Therapeutics stock online?
    You can buy Sarepta Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Oct-16 123.66 125.92 126.35 123.66
Oct-18 124.98 127.08 130.04 124.26
Oct-21 127.73 127.28 129.24 126.58
Oct-22 126.26 128.42 128.54 126.21
Oct-23 131.00 129.88 131.00 126.78
Oct-24 129.90 132.02 132.88 129.53
Oct-25 132.10 131.14 133.36 130.93
Oct-28 131.37 130.26 132.80 129.26
Oct-29 130.07 130.19 131.17 129.26
Oct-30 129.32 127.70 130.86 127.40
Oct-31 127.32 126.00 128.19 125.92
Nov-1 125.91 123.29 126.51 122.68
Nov-4 123.30 123.07 124.03 121.01
Nov-5 123.00 125.01 125.25 121.18

Sarepta Therapeutics Earnings

Sarepta Therapeutics Earnings Report: Per Share Sarepta Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Sarepta Therapeutics Forecast Revenue Growth

Sarepta Therapeutics Stock Analysis: Historical quarterly revenues per share for Sarepta Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $2.72 per share, a decrease next quarter of $0.00 per share, an increase this year of $4.19 per share, and an increase next year of $8.77 per share.

* Sarepta Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.